- Accesswire•4 months ago
NEW YORK, NY / ACCESSWIRE / April 27, 2016 / Development stage biotech company MetaStat Inc ( OTCQB: MTST ) just announced a high-profile, and potentially game changing addition to its board of directors. ...
- Zacks Small Cap Research•7 months ago
The state licensure and CLIA certification follows on the heels of studies validating the performance and accuracy of MTST’s fully automated MetaSite Breast assay. In late August MTST announced the automated (i.e.
- Business Wire•9 months ago
MetaStat, Inc. , a molecular diagnostic company, today presented positive results from an analytical validation study demonstrating the analytical accuracy, reproducibility, and precision of its MetaSite Breast™ test at the Tumor Metastasis meeting of the American Association for Cancer Research in Austin, Texas.
MetaStat, Inc. (MTST)
Other OTC - Other OTC Delayed Price. Currency in USD
|Day's Range||0.00 - 0.00|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-0.43|
|Avg Vol (3m)||436|
|Dividend & Yield||N/A (N/A)|